pediatric-medicine

fda.gov

FDA Approves Zoryve Cream 0.3% for Plaque Psoriasis in Children Age 2 and Older

The Food and Drug Administration approved Zoryve cream 0.3% for treating plaque psoriasis in children as young as age 2. The approval expands the prior indication that covered patients age 6 and older.

FI

3 sources